Your session is about to expire
← Back to Search
Thoracoscopy in Patients With Stage IIIA Non-Small Cell Lung Cancer
N/A
Waitlist Available
Research Sponsored by Alliance for Clinical Trials in Oncology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
RATIONALE: Diagnostic procedures such as thoracoscopy may help to measure a patient's response to previous treatment. PURPOSE: Diagnostic trial to determine the accuracy of thoracoscopy in patients who have stage IIIA non-small cell lung cancer.
Eligible Conditions
- Lung Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: video-thorascopy + surgeryExperimental Treatment1 Intervention
Patients will undergo ipsilateral video-thorascopic evaluation. Patients may undergo surgery at the discretion of the surgeon and treating physicians.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
videothoracoscopy
2004
N/A
~110
Find a Location
Who is running the clinical trial?
Alliance for Clinical Trials in OncologyLead Sponsor
518 Previous Clinical Trials
222,262 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,958 Previous Clinical Trials
41,112,505 Total Patients Enrolled
Michael Jaklitsch, MDStudy ChairDana-Farber/Brigham and Women's Cancer Center